A. Wollenberg, “Safety of tralokinumab in pediatric patients aged 12-17 years with moderate to severe atopic dermatitis: results from the phase 3 ECZTRA 6 trial”, J of Skin, vol. 7, no. 2, p. s140, Mar. 2023.